Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chester B Good
Jing Luo

JAMA network open

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
JAMA Network Open|September 5, 2019
Varenicline and Nicotine Replacement Use Associated With US Food and Drug Administration Drug Safety CommunicationsRavi J Desai, Meghan M Good, Alvaro San-Juan-Rodriguez, et al.
JAMA Network Open|October 5, 2020
Assessment of Use and Safety of Edaravone for Amyotrophic Lateral Sclerosis in the Veterans Affairs Health Care SystemMichelle Vu, Kathryn Tortorice, Jennifer Zacher, et al.
JAMA Network Open|July 28, 2021
Disparities in Anticoagulant Therapy Initiation for Incident Atrial Fibrillation by Race/Ethnicity Among Patients in the Veterans Health Administration SystemUtibe R Essien, Nadejda Kim, Leslie R M Hausmann, et al.
JAMA Network Open|June 12, 2023
Evaluation of Out-of-Pocket Costs and Treatment Intensification With an SGLT2 Inhibitor or GLP-1 RA in Patients With Type 2 Diabetes and Cardiovascular DiseaseJing Luo, Robert Feldman, Katherine Callaway Kim, et al.
JAMA Network Open|April 18, 2022
Potential Gains in Life Expectancy Associated With Achieving Treatment Goals in US Adults With Type 2 DiabetesHamed Kianmehr, Ping Zhang, Jing Luo, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
JAMA Network Open|September 5, 2019
Varenicline and Nicotine Replacement Use Associated With US Food and Drug Administration Drug Safety CommunicationsRavi J Desai, Meghan M Good, Alvaro San-Juan-Rodriguez, et al.
JAMA Network Open|October 5, 2020
Assessment of Use and Safety of Edaravone for Amyotrophic Lateral Sclerosis in the Veterans Affairs Health Care SystemMichelle Vu, Kathryn Tortorice, Jennifer Zacher, et al.
JAMA Network Open|July 28, 2021
Disparities in Anticoagulant Therapy Initiation for Incident Atrial Fibrillation by Race/Ethnicity Among Patients in the Veterans Health Administration SystemUtibe R Essien, Nadejda Kim, Leslie R M Hausmann, et al.
JAMA Network Open|June 12, 2023
Evaluation of Out-of-Pocket Costs and Treatment Intensification With an SGLT2 Inhibitor or GLP-1 RA in Patients With Type 2 Diabetes and Cardiovascular DiseaseJing Luo, Robert Feldman, Katherine Callaway Kim, et al.
JAMA Network Open|April 18, 2022
Potential Gains in Life Expectancy Associated With Achieving Treatment Goals in US Adults With Type 2 DiabetesHamed Kianmehr, Ping Zhang, Jing Luo, et al.
Pageof 1